Disease/Infection News

RSS

Grand Challenges Canada announces $1.2 million in grant for 11 new global health innovations

Grand Challenges Canada, funded by the Government of Canada, today announced $1.2 million in funding for 11 new global health innovations implemented in member states of La Francophonie.

29 Nov 2014

Ansell launches #UniteToFightHIV campaign to raise awareness for World AIDS Day

Ansell, a global leader in protection solutions and the makers of LifeStyles Condoms, one of the nation's leading condom brands, today announced the launch of the #UniteToFightHIV, a social media campaign in partnership with the AIDS Healthcare Foundation to raise awareness for World AIDS Day on December 1, 2014.

29 Nov 2014

Certain mosquito species genetically better at transmitting malaria

Certain species of mosquitoes are genetically better at transmitting malaria than even some of their close cousins, according to a multi-institutional team of researchers including Virginia Tech scientists.

28 Nov 2014

Researchers use mathematical models to predict how immune cells respond to disease

Walter and Eliza Hall Institute researchers have defined for the first time how the size of the immune response is controlled, using mathematical models to predict how powerfully immune cells respond to infection and disease.

28 Nov 2014

Study provides proof of concept for developing antibodies against human pathogens

Scientists investigating the potentially deadly hantavirus have used a novel approach to developing protective antibodies against it. Their work, published in today's online edition of Science Translational Medicine, provides proof of concept for producing antibodies against a broad range of human pathogens.

28 Nov 2014

Ebola vaccine shows promising results in human trial

An experimental vaccine against the Ebola virus has proved effective and well-tolerated in the first human trial of a candidate Ebola drug.

27 Nov 2014

Therapeutic nanoparticle safe, effective against H. pylori infection, shows study

The bacterium Helicobacter pylori is strongly associated with gastric ulcers and cancer. To combat the infection, researchers at University of California, San Diego School of Medicine and Jacobs School of Engineering developed LipoLLA, a therapeutic nanoparticle that contains linolenic acid, a component in vegetable oils.

27 Nov 2014

Experimental Ebola vaccine appears safe, produces immune system responses in NIH phase 1 trial

An experimental vaccine to prevent Ebola virus disease was well-tolerated and produced immune system responses in all 20 healthy adults who received it in a Phase 1 clinical trial conducted by researchers from the National Institutes of Health. The candidate vaccine, which was co-developed by the NIH's National Institute of Allergy and Infectious Diseases and GlaxoSmithKline, was tested at the NIH Clinical Center in Bethesda, Maryland.

27 Nov 2014

BWH researchers identify two-faced role of TIM-3 protein

A Brigham and Women's Hospital-led team has identified a long sought-after partner for a key immune protein, called TIM-3, that helps explain its two-faced role in the immune system -- sometimes dampening it, other times stimulating it. This newly identified partner not only sheds light on the inner workings of the immune system in diseases such as HIV, autoimmunity, and cancer, but also provides a critical path toward the development of novel treatments that target TIM-3.

26 Nov 2014

New hybrid vehicle to improve delivery of DNA vaccines is under development

Described recently in the Proceedings of the National Academy of Sciences, the technology is a biomedical advancement that could help unleash the potential of DNA vaccines, which despite two decades of research, have yet to make a significant impact in the treatment of major illnesses.

26 Nov 2014

Dry powdered measles vaccine triggers no adverse side effects in early human testing

A measles vaccine made of fine dry powder and delivered with a puff of air triggered no adverse side effects in early human testing and it is likely effective, according to a paper to be published November 28 in the journal Vaccine.

26 Nov 2014

Decrease in prevalence of VRSA infections in southeastern Michigan

A new study finds a decrease in an emergent strain of methicillin-resistant S. aureus (MRSA) that is resistant to last line defense antibiotics. Researchers examined the prevalence of vancomycin-resistant Staphylococcus aureus (VRSA) infections in southeastern Michigan, where the majority of these infections have occurred in the U.S.

26 Nov 2014

Study: Using wash cloths treated with skin cleanser could reduce skin infections in U.S. jails

New research shows providing detainees wash cloths treated with a skin cleanser could reduce the prevalence of Staphylococcus aureus (S. aureus) bacteria in U.S. jails. Researchers looked at the effect on transmission of S. aureus of using wash cloths treated with chlorhexidine gluconate (CHG) compared with wash cloths with only plain water in detainees at Dallas County Jail.

25 Nov 2014

Jhpiego, SAGO partner to expand Ebola preparedness training across West Africa

Jhpiego is partnering with the Society of African Gynecologists and Obstetricians to expand and reinforce Ebola preparedness training for frontline health workers across West Africa in the event the virus outbreak spreads further in the region.

25 Nov 2014

South Africa's response to Ebola outbreak

Brand South Africa and the Department of Communications yesterday convened a high level discussion with stakeholders on how the country is responding to the Ebola outbreak in West Africa.

25 Nov 2014

New Mayo Clinic study shows impact of long-term use of proton pump inhibitors

Before reaching for that daily antacid, you might consider what it's doing to the trillions of bugs living in your gut. A new Mayo Clinic study in the open access journal Microbiome shows that people who regularly take proton pump inhibitors (PPIs) have less diversity among their gut bacteria, putting them at increased risk for infections like clostridium difficile and pneumonia, in addition to vitamin deficiencies and bone fractures.

25 Nov 2014

Study finds that starting ART treatment soon after HIV infection improves immune health

HIV-1-infected U.S. military members and beneficiaries treated with antiretroviral therapy (ART) soon after infection were half as likely to develop AIDS and were more likely to reconstitute their immune-fighting CD4+ T-cells to normal levels, researchers reported Nov. 24 in JAMA Internal Medicine.

25 Nov 2014

Provider-centered multi-component PI CME intervention improves HPV vaccination rates

Changing the way doctors practice medicine is difficult, however a new study has shown that combining traditional education with quality improvement and incentives improves Human Papilloma virus (HPV) vaccination rates in boys and girls. The study, which appears on-line in the journal Vaccine, has the potential to produce sustained improvements in these vaccination rates.

25 Nov 2014

Gates Foundation provides $2 million grant to help fight major parasitic diseases

Almost $2 million is being invested by the Bill & Melinda Gates Foundation to help fight major parasitic diseases of the developing world.

25 Nov 2014

Johns Hopkins researchers develop online tool to speed up creation of new drugs to prevent Ebola virus

Johns Hopkins biomedical engineers have developed a free, browser-based online tool that could speed up the creation of new drugs to treat or prevent Ebola virus infections.

24 Nov 2014

Disease/Infection News

Grand Challenges Canada announces $1.2 million in grant for 11 new global health innovations

Ansell launches #UniteToFightHIV campaign to raise awareness for World AIDS Day

Certain mosquito species genetically better at transmitting malaria

Researchers use mathematical models to predict how immune cells respond to disease

Study provides proof of concept for developing antibodies against human pathogens

Ebola vaccine shows promising results in human trial

Therapeutic nanoparticle safe, effective against H. pylori infection, shows study

Experimental Ebola vaccine appears safe, produces immune system responses in NIH phase 1 trial

BWH researchers identify two-faced role of TIM-3 protein

New hybrid vehicle to improve delivery of DNA vaccines is under development

Dry powdered measles vaccine triggers no adverse side effects in early human testing

Decrease in prevalence of VRSA infections in southeastern Michigan

Study: Using wash cloths treated with skin cleanser could reduce skin infections in U.S. jails

Jhpiego, SAGO partner to expand Ebola preparedness training across West Africa

South Africa's response to Ebola outbreak

New Mayo Clinic study shows impact of long-term use of proton pump inhibitors

Study finds that starting ART treatment soon after HIV infection improves immune health

Provider-centered multi-component PI CME intervention improves HPV vaccination rates

Gates Foundation provides $2 million grant to help fight major parasitic diseases

Johns Hopkins researchers develop online tool to speed up creation of new drugs to prevent Ebola virus

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News